Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-01-09

Clinical Trial Update: Effect of House Dust Mite Allergen Challenge in Persons Using 1200 mg Gamma Tocopherol Supplements [Phase 1]

View source ↗

Summary

This completed Phase 1 trial investigates how daily 1200 mg gamma-tocopherol supplementation affects responses to house dust mite allergen exposure in adults wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Gamma Tocopherol supplement (gamma-tocopherol)

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: Allergic Rhinitis, Mild Asthma | Phase 1 | Status: COMPLETED